HIV/AIDS News

Three-quarters of people globally living with HIV are on ART, a roughly 30% increase during the last nine years, and fewer people acquired HIV in 2023 than at any point since the late 1980s, UNAIDS reported.

A self-management program tailored to individuals with HIV significantly reduced the impact and severity of chronic pain, according to results from a randomized study published in JAMA Internal Medicine.

In June, Gilead Sciences announced that its investigational antiretroviral drug lenacapavir prevented 100% of new HIV infections during a phase 3 trial conducted among cisgender women in Africa.

Despite global progress toward eliminating HIV — including a growing number of nations that have hit goals to diagnose and successfully treat patients — funding pullbacks threaten to add decades to the battle, according to a study.

Post-exposure prophylaxis for HIV remained significantly underutilized, especially in acute care settings, according to study results published in Open Forum Infectious Diseases.

Long-acting injectable PrEP is feasible and acceptable to both men and women, according to a study presented at the AIDS 2024 meeting in Munich.

A seventh person has potentially been cured of HIV after receiving a stem cell transplant to treat blood cancer, researchers announced on the eve of the 25th International AIDS Conference.

Only about half of gay or bisexual men received recommended sexually transmitted infection testing at their initial visit to a private, outpatient facility, researchers reported.

Patients with HIV who undergo immediate antiretroviral therapy may not experience significant differences in chronic kidney disease outcomes compared with patients who defer treatment.

Patients receiving infectious diseases consultation over the past decade were increasingly complex, generally sicker and more likely to die soon after a consultation was performed.